Recalls, Availability, and Content of Dietary Supplements Following FDA Warning Letters
Authors:
Open Access
- 26 July 2022
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 328 (4) , 393-395
Abstract
Some dietary supplements are adulterated with novel and unapproved stimulants. These analogues of amphetamine, ephedrine, and other drugs have been linked to serious health risks, including hemorrhagic stroke and sudden death. The US Food and Drug Administration (FDA) is responsible for removing these hazardous supplements from the market, and the agency has attempted to do so by issuing warning letters to manufacturers (Supplement).1-3Keywords
This publication has 3 references indexed in Scilit:
- Liquid chromatography-quadrupole time of flight mass spectrometric method for targeted analysis of 111 nitrogen-based compounds in weight loss and ergogenic supplementsJournal of Pharmaceutical and Biomedical Analysis, 2019
- Prohibited Stimulants in Dietary Supplements After Enforcement Action by the US Food and Drug AdministrationJAMA Internal Medicine, 2018
- Presence of Banned Drugs in Dietary Supplements Following FDA RecallsJAMA, 2014